Financing round-up: Valbiotis, PureFDA, Orionis Biosciences, NRG Therapeutics, Pulnovo Medical

China: Pulnovo Medical, an OTM (from Operating Table to Market) platform, has closed its latest financing round of an undisclosed amount totalling millions of dollars. The financing was led by YuanBio Venture Capital. Other investors included Orbimed Healthcare Fund Management, Cenova Capital, Lilly Asia Ventures (LAV), GaoRong Capital, Huihe Capital and GC&H Investments. Funding will…